Trial intelligence / Profile preview

WAVE: Women's Angiographic Vitamin and Estrogen Trial

NCT00000555Phase 3Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Aug 1996
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 3 trial of estradiol valerate + dydrogesterone, vitamin e, ascorbic acid in coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Aug 1996; status: completed.

02

Drugs

estradiol valerate + dydrogesteronevitamin eascorbic acid
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00000555.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000555.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call